ATE383855T1 - Behandlung von reizkolon-syndrom oder -krankheit - Google Patents
Behandlung von reizkolon-syndrom oder -krankheitInfo
- Publication number
- ATE383855T1 ATE383855T1 AT01934671T AT01934671T ATE383855T1 AT E383855 T1 ATE383855 T1 AT E383855T1 AT 01934671 T AT01934671 T AT 01934671T AT 01934671 T AT01934671 T AT 01934671T AT E383855 T1 ATE383855 T1 AT E383855T1
- Authority
- AT
- Austria
- Prior art keywords
- treatment
- disease
- irritable colon
- colon syndrome
- irritable bowel
- Prior art date
Links
- 208000002551 irritable bowel syndrome Diseases 0.000 title abstract 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 2
- 201000010099 disease Diseases 0.000 title 1
- QAKXLTNAJLFSQC-UHFFFAOYSA-N hexadecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC QAKXLTNAJLFSQC-UHFFFAOYSA-N 0.000 abstract 2
- FLPJVCMIKUWSDR-UHFFFAOYSA-N 2-(4-formylphenoxy)acetamide Chemical compound NC(=O)COC1=CC=C(C=O)C=C1 FLPJVCMIKUWSDR-UHFFFAOYSA-N 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 229940074979 cetyl palmitate Drugs 0.000 abstract 1
- 239000002552 dosage form Substances 0.000 abstract 1
- PXDJXZJSCPSGGI-UHFFFAOYSA-N hexadecanoic acid hexadecyl ester Natural products CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC PXDJXZJSCPSGGI-UHFFFAOYSA-N 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NZ50452400 | 2000-05-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE383855T1 true ATE383855T1 (de) | 2008-02-15 |
Family
ID=19927880
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01934671T ATE383855T1 (de) | 2000-05-12 | 2001-05-11 | Behandlung von reizkolon-syndrom oder -krankheit |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US6696491B2 (de) |
| EP (1) | EP1282412B1 (de) |
| AT (1) | ATE383855T1 (de) |
| AU (1) | AU775941B2 (de) |
| CA (1) | CA2408537C (de) |
| DE (1) | DE60132444T2 (de) |
| ES (1) | ES2299484T3 (de) |
| WO (1) | WO2001085162A1 (de) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030153620A1 (en) | 2000-05-12 | 2003-08-14 | Meakin Timothy David | Treating eczema and/or psoriasis |
| ATE381327T1 (de) * | 2000-05-12 | 2008-01-15 | Meracol Corp Ltd | Cethylmyristat und cetylpalmitat zurbehandlung von ekzemen und/oder psoriasis |
| US20040086581A1 (en) * | 2002-11-06 | 2004-05-06 | Jones Edwin B. | Bio-energetic joint and arthritis pain formula |
| EP1617830A4 (de) * | 2003-03-20 | 2008-09-24 | Imagenetix Inc | Veresterte fettsäurezusammensetzung |
| US20050032892A1 (en) * | 2003-08-07 | 2005-02-10 | The Procter & Gamble Company | Compositions, kits, and methods for treating gastrointestinal conditions |
| US7776914B2 (en) | 2004-03-22 | 2010-08-17 | Imagenetix, Inc. | Esterified fatty acid composition |
| NZ533370A (en) * | 2004-06-03 | 2006-11-30 | Meracol Corp Ltd | Use of cetyl myristate and cetyl palmitate in therapy for multiple sclerosis |
| US8152372B1 (en) * | 2008-04-17 | 2012-04-10 | Marvell International Ltd. | Methods for monitoring chip temperature during test |
| KR20100049272A (ko) * | 2008-11-03 | 2010-05-12 | 에스케이케미칼주식회사 | 과민성 장 증후군의 예방 및 치료용 조성물 |
| EP2441446A1 (de) | 2010-10-14 | 2012-04-18 | Deva Holding Anonim Sirketi | Verwendung von Supersprengmittel in Cetylmyristat und/oder Cetylpalmitatformulierungen |
| EP2441441A1 (de) | 2010-10-14 | 2012-04-18 | Deva Holding Anonim Sirketi | Siebverfahren für Cetylmyristat und/oder Cetylpalmitat |
| EP2589378A1 (de) | 2010-10-14 | 2013-05-08 | Deva Holding Anonim Sirketi | Cetylmyristat- und/oder Cetylpalmitatteilchenbeschichtung |
| EP2441444A1 (de) | 2010-10-14 | 2012-04-18 | Deva Holding Anonim Sirketi | Formulierungen von Cetylmyristat und/oder Cetylpalmitat |
| EP2471384A1 (de) | 2010-12-29 | 2012-07-04 | Deva Holding Anonim Sirketi | Suspensions Formulierungen für Cetyl myristat und/oder Cetyl palmitat |
| EP2471514A1 (de) | 2010-12-29 | 2012-07-04 | Deva Holding Anonim Sirketi | Kontrollierter Feuchtigkeitsgehalt von Cetyl Myristat und/oder Cetyl Palmitat Granulaten oder Formulierungen |
| EP2471386A1 (de) | 2010-12-29 | 2012-07-04 | Deva Holding Anonim Sirketi | Suspensionsformulierungen für Cetylmyristat und/oder Cetylpalmitat |
| EP2471528A1 (de) | 2010-12-29 | 2012-07-04 | Deva Holding Anonim Sirketi | Eine Herstellungsmethode für Cetyl Myristat und/oder Cetyl Palmitat Suspensionen |
| EP2471387A1 (de) | 2010-12-29 | 2012-07-04 | Deva Holding Anonim Sirketi | Suspensionsformulierungen für Cetylmyristat und/oder Cetylpalmitat |
| EP2471385A1 (de) | 2010-12-29 | 2012-07-04 | Deva Holding Anonim Sirketi | Suspensionsformulierungen für Cetylmyristat und/oder Cetylpalmitat |
| EP2526931B1 (de) | 2011-05-23 | 2014-12-17 | Deva Holding Anonim Sirketi | Nasse Granulationsmethoden für Cetylmyristat und/oder Cetylpalmitat |
| EP2526936B1 (de) | 2011-05-23 | 2015-04-15 | Deva Holding Anonim Sirketi | Partikelgrößenverteilung für Cetyl myristat und / oder Cetyl Palmitat |
| ITUB20153130A1 (it) * | 2015-08-14 | 2017-02-14 | Pharmanutra S P A | Acidi grassi cetilati, impianto per la loro preparazione e relativo uso |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU195729B (en) | 1985-02-05 | 1988-07-28 | Sandoz Ag | Process for producing pharmaceutical compositions containing 9,10-dihydro-ergot-alkaloides |
| DE4308282C2 (de) * | 1993-03-16 | 1994-12-22 | Beiersdorf Ag | Vorzugsweise in Form von Mikrosphärulen vorliegende galenische Matrices |
| DE19819273A1 (de) | 1998-04-30 | 1999-11-11 | Pharmatec International S Giul | Pharmazeutische Ciclosporin-Formulierung mit verbesserten biopharmazeutischen Eigenschaften, erhöhter physikalischer Qualität und Stabilität sowie Verfahren zur Herstellung |
| CA2329252A1 (en) * | 1998-05-21 | 1999-11-25 | Isis Pharmaceuticals Inc. | Compositions and methods for topical delivery of oligonucleotides |
| GB9810949D0 (en) | 1998-05-22 | 1998-07-22 | Hewlett Healthcare Limited | Formulation |
| US6284234B1 (en) * | 1998-08-04 | 2001-09-04 | Johnson & Johnson Consumer Companies, Inc. | Topical delivery systems for active agents |
| AU4917900A (en) | 1999-05-07 | 2000-11-21 | Pharmasol Gmbh | Lipid particles on the basis of mixtures of liquid and solid lipids and method for producing same |
| ATE381327T1 (de) * | 2000-05-12 | 2008-01-15 | Meracol Corp Ltd | Cethylmyristat und cetylpalmitat zurbehandlung von ekzemen und/oder psoriasis |
-
2001
- 2001-05-11 AT AT01934671T patent/ATE383855T1/de not_active IP Right Cessation
- 2001-05-11 AU AU60832/01A patent/AU775941B2/en not_active Ceased
- 2001-05-11 DE DE60132444T patent/DE60132444T2/de not_active Expired - Lifetime
- 2001-05-11 US US10/275,270 patent/US6696491B2/en not_active Expired - Fee Related
- 2001-05-11 WO PCT/NZ2001/000084 patent/WO2001085162A1/en not_active Ceased
- 2001-05-11 EP EP01934671A patent/EP1282412B1/de not_active Expired - Lifetime
- 2001-05-11 ES ES01934671T patent/ES2299484T3/es not_active Expired - Lifetime
- 2001-05-11 CA CA002408537A patent/CA2408537C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP1282412A1 (de) | 2003-02-12 |
| CA2408537A1 (en) | 2001-11-15 |
| DE60132444D1 (de) | 2008-03-06 |
| AU775941B2 (en) | 2004-08-19 |
| US20030171432A1 (en) | 2003-09-11 |
| WO2001085162A1 (en) | 2001-11-15 |
| US6696491B2 (en) | 2004-02-24 |
| EP1282412A4 (de) | 2004-02-25 |
| AU6083201A (en) | 2001-11-20 |
| CA2408537C (en) | 2009-07-28 |
| ES2299484T3 (es) | 2008-06-01 |
| EP1282412B1 (de) | 2008-01-16 |
| DE60132444T2 (de) | 2009-01-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE383855T1 (de) | Behandlung von reizkolon-syndrom oder -krankheit | |
| EA200800375A1 (ru) | Соединения и способы ингибирования экспрессии vcam-1 | |
| DE69200685D1 (de) | Benzocyclobutyl- oder Indanyl-Alkyl-Amino-Alkyl substituierte 3-Benzazepin-2-ones, verwendbar in der Behandlung von kardiovaskularen Krankheiten. | |
| CY1107242T1 (el) | Μυριστικο κητυλιο και παλμικο κητυλιο για τη θεραπεια του εκζεματος ή/και της ψωριασης | |
| EA200000920A1 (ru) | Производные бициклических гидроксамовых кислот | |
| TR199903034T2 (xx) | Piperazin t�revleri ve anti-enflamatuvar ajan olarak kullan�mlar�. | |
| FR2757520B1 (fr) | Derive de cyclosporine, sa preparation et les compositions pharmaceutiques qui le contiennent | |
| EA200000994A1 (ru) | Применение кабэрголина при лечении синдрома усталых ног | |
| ATE303993T1 (de) | 4-hydroxychinolin-3-carboxamide und hydrazide als antivirale wirkstoffe | |
| EA200000608A1 (ru) | Предотвращение и лечение амилоидогенного заболевания | |
| EP1240280A4 (de) | Behandlung von kohle | |
| SE9904674D0 (sv) | Novel compounds | |
| TR200100637T2 (tr) | Yeni doğal ürün türevleri | |
| TR200402070T4 (tr) | Siklobüten-dion türevleri ve bunların damar sertliği tedavisinde kullanımı | |
| DE60035996D1 (de) | Diätetisches kalzium als ergänzung zu vitamin d verbindungen bei der behandlung von multipler sklerose | |
| DE69613395D1 (de) | Schwefelenthaltende di-ter-butylphenol-verbindungen brauchbar als entzündungshemmende mittel | |
| DE69514100D1 (de) | Substituierte kondensierte und verbrückte bicyclische verbindungen als therapeutische mittel | |
| DE60110748D1 (de) | Behandlung von fluorkohlenstoff-beschickungen | |
| DE60103685D1 (de) | Behandlung von Poriomania | |
| FR2645145B1 (fr) | Compositions cosmetiques et pharmaceutiques contenant des derives lipophiles du benzylidene camphre et nouveaux derives lipophiles du benzylidene camphre | |
| NO20005548D0 (no) | Mykobakterieinhibitorer | |
| DE69230644D1 (de) | Verwendung von protease nexin-i als mittel gegen entzündungen | |
| MXPA03001644A (es) | Composiciones y metodos para el diagnostico y tratamiento de tumor. | |
| CY1105373T1 (el) | Ισοκινολινυλικα καρβοξαμιδια και η χρηση τους ως αντισπαστικα | |
| FR2664599B1 (fr) | Vinylsulfonyl pristinamycine et sa preparation. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1282412 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |